{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:52:55Z","timestamp":1789635175811,"version":"4.0.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.tox.2011.01.006","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T07:09:08Z","timestamp":1294988948000},"page":"7-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma"],"prefix":"10.1016","volume":"281","author":[{"given":"Andreas","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Braeuning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Armeanu-Ebinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Warmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2011.01.006_bib0005","article-title":"Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model","author":"Armengol","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.tox.2011.01.006_bib0010","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1124\/dmd.108.026179","article-title":"Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1","volume":"37","author":"Braeuning","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2011.01.006_bib0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of Wnt\/\u03b2-Catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Cairo","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tox.2011.01.006_bib0020","first-page":"989","article-title":"Intrasplenic transplantation of isolated periportal and perivenous hepatocytes as a long-term system for study of liver-specific gene expression","volume":"19","author":"Chen","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2011.01.006_bib0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.1993.11.1.96","article-title":"Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study","volume":"11","author":"Douglass","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tox.2011.01.006_bib0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/cncr.10632","article-title":"Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94","volume":"95","author":"Fuchs","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.tox.2011.01.006_bib0035","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/j.1460-2075.1983.tb01464.x","article-title":"Heterogeneous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture","volume":"2","author":"Gebhardt","year":"1983","journal-title":"EMBO J."},{"key":"10.1016\/j.tox.2011.01.006_bib0040","first-page":"1","article-title":"Caught up in a Wnt storm: Wnt signaling in cancer","volume":"1653","author":"Giles","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tox.2011.01.006_bib0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1067\/mcp.2001.117283","article-title":"Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin","volume":"70","author":"Kerbusch","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2011.01.006_bib0050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1248\/bpb1978.12.341","article-title":"Immunochemical studies for the presence of P-450 HFLa, a form of cytochrome P-450 in human fetal livers in human hepatocellular carcinoma cells","volume":"12","author":"Kitada","year":"1989","journal-title":"J. Pharmacobiodyn."},{"key":"10.1016\/j.tox.2011.01.006_bib0055","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/pbc.20330","article-title":"Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith\u2013Wiedemann syndrome with high dose acetaminophen and N-acetylcysteine rescue","volume":"45","author":"Kobrinsky","year":"2005","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.tox.2011.01.006_bib0060","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/path.1662","article-title":"Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas","volume":"204","author":"Koch","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.tox.2011.01.006_bib0065","first-page":"675","article-title":"Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver","volume":"7","author":"Komatsu","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tox.2011.01.006_bib0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jhep.2005.01.036","article-title":"The RL-ET-14 cell line mediates expression of glutamine synthetase through the upstream enhancer\/promoter region","volume":"43","author":"Kruithof-de Julio","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2011.01.006_bib0075","first-page":"6050","article-title":"Evidence that interaction of hepatocytes with the collecting (hepatic) veins triggers position-specific transcription of the glutamine synthetase and ornithine aminotransferase genes in the mouse liver","volume":"11","author":"Kuo","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tox.2011.01.006_bib0080","first-page":"395","article-title":"Codon 45 of the \u03b2-Catenin gene, a specific mutational target site of Wilms\u2019 tumor","volume":"10","author":"Kusafuka","year":"2002","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.tox.2011.01.006_bib0085","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1152\/ajplegacy.1976.231.4.1068","article-title":"Glutamine synthetase and glutamyltransferase in the kidney of man, dog, and rat","volume":"231","author":"Lemieux","year":"1976","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.tox.2011.01.006_bib0090","first-page":"5685","article-title":"Overexpression of glutamine synthetase is associated with \u03b2-Catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital","volume":"62","author":"Loeppen","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2011.01.006_bib0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/carcin\/bgh298","article-title":"A \u03b2-Catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors","volume":"26","author":"Loeppen","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2011.01.006_bib0100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","article-title":"Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and notch pathway activation in DLK+ precursors","volume":"40","author":"Lopez-Terrada","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.tox.2011.01.006_bib0105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/mol.104.005371","article-title":"Antitumor activity of methoxymorpholinyl doxorubicin: potentiation by cytochrome P450 3A metabolism","volume":"67","author":"Lu","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2011.01.006_bib0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/toxsci\/kfj031","article-title":"Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1","volume":"89","author":"Lu","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2011.01.006_bib0115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1386-6346(02)00264-4","article-title":"Sequence variants of the axin gene in hepatoblastoma","volume":"25","author":"Miao","year":"2003","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.tox.2011.01.006_bib0120","first-page":"3320","article-title":"Somatic mutations of the APC gene in sporadic hepatoblastomas","volume":"56","author":"Oda","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2011.01.006_bib0125","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma","volume":"361","author":"Perilongo","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2011.01.006_bib0130","first-page":"1557","article-title":"Alcohol-mediated increases in acetaminophen hepatotoxicity: role of CYP2E and CYP3A","volume":"55","author":"Sinclair","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2011.01.006_bib0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20768","article-title":"Genotype\u2013phenotype relationships in hepatocellular tumors from mice and man","volume":"42","author":"Stahl","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2011.01.006_bib0140","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.ejca.2006.05.011","article-title":"Liver cancer in European children: incidence and survival, 1978\u20131997. Report from the Automated Childhood Cancer Information System project","volume":"42","author":"Stiller","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tox.2011.01.006_bib0145","series-title":"World Health Organization Classification of Tumors","article-title":"Pathology and genetics of tumours of the digestive system, hepatoblastoma","author":"Stocker","year":"2000"},{"key":"10.1016\/j.tox.2011.01.006_bib0150","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1038\/sj.onc.1205591","article-title":"Mutational spectrum of \u03b2-Catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas","volume":"21","author":"Taniguchi","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.tox.2011.01.006_bib0155","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s003830000576","article-title":"High frequency of \u03b2-Catenin mutations in hepatoblastoma","volume":"17","author":"Udatsu","year":"2001","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.tox.2011.01.006_bib0160","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0959-8049(97)00095-6","article-title":"Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma, Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology","volume":"33","author":"von Schweinitz","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tox.2011.01.006_bib0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/mpo.1276","article-title":"Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood","volume":"38","author":"Vujanic","year":"2002","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.tox.2011.01.006_bib0170","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/sj.onc.1203356","article-title":"Activation of \u03b2-Catenin in epithelial and mesenchymal hepatoblastomas","volume":"19","author":"Wei","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.tox.2011.01.006_bib0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0959-437X(98)80068-3","article-title":"\u03b2-Catenin: a key mediator of Wnt signaling","volume":"8","author":"Willert","year":"1998","journal-title":"Curr. Opin. Genet. Dev."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X11000102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X11000102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:13:48Z","timestamp":1759533228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X11000102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":35,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0300483X11000102"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2011.01.006","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2011.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}